HealthQuill Drugs
The world’s first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the WHO stated.
Drugs Health Medical

First vaccine efficacy trial for Sudan Ebola during an outbreak starts in Uganda

The world’s first-ever clinical efficacy trial of a vaccine for Ebola disease arising out of the Sudan virus has started in Uganda, the.

Read More
Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global health agency after the nation withdrew from being a member.
Drugs Health Medical

WHO director-general rebuts US criticism, plans to cut budget

Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization, has given a four-point rebuttal to the US government’s accusations against the global.

Read More
Global researchers, led by Australia’s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the world’s first synthetic yeast genome following more than a decade of work.
Drugs Health Medical

Global researchers complete world’s first synthetic yeast genome project

Global researchers, led by Australia’s Macquarie University, in a bid to re-engineer life in a laboratory, have completed the world’s first synthetic yeast.

Read More
overuse of cannabis can result in impaired memory
Drugs Research

Heavy cannabis use reduces brain activity during memory tasks

Bharti Jayshankar February 1, 2025: A study published in JAMA Network Open reveals that heavy cannabis use may impair brain function during critical.

Read More
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Read More
Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.
Drugs Health Medical

Vertex’s non-opioid painkiller receives approval from US drug regulator

Vertex Pharmaceuticals Inc.’s non-opioid analgesic to treat moderate to severe acute pain in adults got approval from the US drug regulator.

Read More
Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to a National Institute for Health and Care Excellence (NICE) statement.
Drugs Health Medical

UK’s NHS to provide gene therapy that may cure sickle cell  disease in adults

Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to.

Read More
Merck & Co. halted its final-phase study of its experimental drug for pulmonary arterial hypertension after previous studies proved its “robust efficacy,” according to a company statement.
Drugs Health Medical

Merck & Co stops final-stage drug trial for treating PAH

Merck & Co. halted its final-phase study of its experimental drug for pulmonary arterial hypertension after previous studies proved its “robust efficacy,” according.

Read More
The UNAIDS has welcomed a move by the United States Secretary of State, Marco Rubio, to approve an “Emergency Humanitarian Waiver” to allow people to continue accessing HIV treatment funded by the US across 55 countries worldwide.
Drugs Health Medical

US ‘humanitarian wavier’ will help deliver life-saving HIV medicines: UN

The UNAIDS has welcomed a move by the United States Secretary of State, Marco Rubio, to approve an “Emergency Humanitarian Waiver” to allow.

Read More
Eli Lilly has stopped trials of its investigational drug to treat chronic kidney disease for a “lack of foreseeable clinical benefit,” according to a company statement.
Drugs Health Medical

Eli Lilly halts trials of investigational chronic kidney disease drug

Eli Lilly has stopped trials of its investigational drug to treat chronic kidney disease for a “lack of foreseeable clinical benefit,” according to.

Read More